KIT and lung carcinoma: Through fluorescence-labeling of FA-mExo-siRNA-c-kit and mExo-siRNA-c-kit, followed by co-incubation with lung cancer cells for 48 h, the highest fluorescent intensity was observed in gefitinib-resistant lung cancer cells treated with FA-mExo-siRNA-c-kit (Figure 3F and 3G).